๐Ÿ”ฌDeep Research

BEAM โ€” Beam Therapeutics ยท catalysts, narrative & risks

ยท21 sourcesBEAM forecast โ†’

Beam Therapeutics (BEAM) โ€” Point-in-Time Research as of 2026-11-10

Note: figures below are compiled from the provided sources and are not a recommendation.

Quick facts: Market cap ~$2.73B, 103.5M shares outstanding, ~$26.41 closing price on Nov 6, 2026 [10]; trading around $26โ€“27 [6][10]. NASDAQ-listed, Healthcare/Biotechnology [background].

Recent catalysts (last ~1โ€“3 months, Augโ€“Nov 2026)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’